Medcura, Inc.
Last verified 2026-06-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $38.3Mattributed |
|---|---|
| Latest round | Funding round, $38.3M, 2025-07-25attributed |
| Founded | unknown |
| Headquarters | Riverdale, Maryland |
| Industry | biotechnology |
| Stage | unknown |
| Website | medcurainc.com |
Medcura develops biopolymer hemostatic products that mechanically coat bleeding sites to control surgical, trauma, and consumer bleeding, led by its LifeGel gel for spine surgery. It serves surgeons, trauma settings, and payers seeking lower-cost hemostasis. Its edge is a flowable gel that resists swelling, with FDA Breakthrough Device designation.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-07-25 | Funding round | $38.3M | undisclosed |
Detected tech stack
@sentry/browser, cloudflare, google font api, google hosted libraries, hsts, http/3, jquery 3.5.1, wistia
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $38.3M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $38.3M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | medcurainc.com, read 2026-06-05 |
| Description | self-reported | medcurainc.com, read 2026-06-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $38.3M, 2025-07-25 → Funding round, $38.3M, 2025-07-25, sec-edgar, No document URL on file | Latest round | seed, $38.3M, 2025-07-25 → Funding round, $38.3M, 2025-07-25 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes